TScan Therapeutics, Inc. Common Stock (TCRX) is a publicly traded Healthcare sector company. As of September 30, 2026, TCRX trades at $0.33 with a market cap of $21.52M and a P/E ratio of -0.36. TCRX moved +0.79% today. Year to date, TCRX is -68.25%; over the trailing twelve months it is -81.75%. Its 52-week range spans $0.29 to $2.57. Analyst consensus is neutral with an average price target of $1.00. Rallies surfaces TCRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
TScan Therapeutics, Inc. Common Stock (TCRX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TCRX moved +0.79% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $0.33 |
| Market Cap | $21.52M |
| P/E Ratio | -0.36 |
| EPS | $-0.91 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.57 |
| 52-Week Low | $0.29 |
| Volume | 533.72K |
| Avg Volume | 0 |
| Revenue (TTM) | $7.11M |
| Net Income | $-117.71M |
| Gross Margin | 0.00% |
6 analysts cover TCRX: 0 strong buy, 1 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $1.00.